396 related articles for article (PubMed ID: 30503283)
1. The Hairpin Form of r(G
Wang ZF; Ursu A; Childs-Disney JL; Guertler R; Yang WY; Bernat V; Rzuczek SG; Fuerst R; Zhang YJ; Gendron TF; Yildirim I; Dwyer BG; Rice JE; Petrucelli L; Disney MD
Cell Chem Biol; 2019 Feb; 26(2):179-190.e12. PubMed ID: 30503283
[TBL] [Abstract][Full Text] [Related]
2. A Small Molecule Exploits Hidden Structural Features within the RNA Repeat Expansion That Causes c9ALS/FTD and Rescues Pathological Hallmarks.
Ursu A; Baisden JT; Bush JA; Taghavi A; Choudhary S; Zhang YJ; Gendron TF; Petrucelli L; Yildirim I; Disney MD
ACS Chem Neurosci; 2021 Nov; 12(21):4076-4089. PubMed ID: 34677935
[TBL] [Abstract][Full Text] [Related]
3. Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G
Bush JA; Aikawa H; Fuerst R; Li Y; Ursu A; Meyer SM; Benhamou RI; Chen JL; Khan T; Wagner-Griffin S; Van Meter MJ; Tong Y; Olafson H; McKee KK; Childs-Disney JL; Gendron TF; Zhang Y; Coyne AN; Wang ET; Yildirim I; Wang KW; Petrucelli L; Rothstein JD; Disney MD
Sci Transl Med; 2021 Oct; 13(617):eabd5991. PubMed ID: 34705518
[TBL] [Abstract][Full Text] [Related]
4. Conformational dynamics of RNA G4C2 and G2C4 repeat expansions causing ALS/FTD using NMR and molecular dynamics studies.
Taghavi A; Baisden JT; Childs-Disney JL; Yildirim I; Disney MD
Nucleic Acids Res; 2023 Jun; 51(11):5325-5340. PubMed ID: 37216594
[TBL] [Abstract][Full Text] [Related]
5. Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.
Ursu A; Wang KW; Bush JA; Choudhary S; Chen JL; Baisden JT; Zhang YJ; Gendron TF; Petrucelli L; Yildirim I; Disney MD
ACS Chem Biol; 2020 Dec; 15(12):3112-3123. PubMed ID: 33196168
[TBL] [Abstract][Full Text] [Related]
6. A blood-brain penetrant RNA-targeted small molecule triggers elimination of r(G
Bush JA; Meyer SM; Fuerst R; Tong Y; Li Y; Benhamou RI; Aikawa H; Zanon PRA; Gibaut QMR; Angelbello AJ; Gendron TF; Zhang YJ; Petrucelli L; Heick Jensen T; Childs-Disney JL; Disney MD
Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2210532119. PubMed ID: 36409902
[TBL] [Abstract][Full Text] [Related]
7. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
[TBL] [Abstract][Full Text] [Related]
8. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
9. All in the Family: Repeats and ALS/FTD.
Pattamatta A; Cleary JD; Ranum LPW
Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
[TBL] [Abstract][Full Text] [Related]
10. Disease Mechanisms of
Gendron TF; Petrucelli L
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314
[TBL] [Abstract][Full Text] [Related]
11. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
[TBL] [Abstract][Full Text] [Related]
12. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
13. RNA-mediated toxicity in C9orf72 ALS and FTD.
McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
[TBL] [Abstract][Full Text] [Related]
14. C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten.
Stopford MJ; Higginbottom A; Hautbergue GM; Cooper-Knock J; Mulcahy PJ; De Vos KJ; Renton AE; Pliner H; Calvo A; Chio A; Traynor BJ; Azzouz M; Heath PR; ; Kirby J; Shaw PJ
Hum Mol Genet; 2017 Mar; 26(6):1133-1145. PubMed ID: 28158451
[TBL] [Abstract][Full Text] [Related]
15. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.
Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.
Su Z; Zhang Y; Gendron TF; Bauer PO; Chew J; Yang WY; Fostvedt E; Jansen-West K; Belzil VV; Desaro P; Johnston A; Overstreet K; Oh SY; Todd PK; Berry JD; Cudkowicz ME; Boeve BF; Dickson D; Floeter MK; Traynor BJ; Morelli C; Ratti A; Silani V; Rademakers R; Brown RH; Rothstein JD; Boylan KB; Petrucelli L; Disney MD
Neuron; 2014 Sep; 83(5):1043-50. PubMed ID: 25132468
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
18. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
19. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.
Yuva-Aydemir Y; Almeida S; Gao FB
Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808
[TBL] [Abstract][Full Text] [Related]
20. Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence.
Zhou B; Geng Y; Liu C; Miao H; Ren Y; Xu N; Shi X; You Y; Lee T; Zhu G
Sci Rep; 2018 Feb; 8(1):2366. PubMed ID: 29402965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
